Next Article in Journal
Musculoskeletal Magazine Advertising Focuses on White Individuals and Overlooks Minority Consumers
Next Article in Special Issue
Agenzia Italiana del Farmaco (AIFA): Developments and Strategy in a Transitioning European HTA Landscape
Previous Article in Journal
Multi-Year Multi-Indication Agreements for Supporting Patient Access to Oncology Medicines with Multiple Indications: An Experimental Approach or Here to Stay?
Previous Article in Special Issue
Technology Assessment vs. Technology Appraisal—How to Strengthen the Science/Value Dichotomy with EU HTA?
 
 
Opinion

Article Versions Notes

J. Mark. Access Health Policy 2025, 13(1), 3; https://doi.org/10.3390/jmahp13010003
Action Date Notes Link
article xml file uploaded 30 January 2025 18:42 CET Original file -
article xml uploaded. 30 January 2025 18:42 CET Update -
article pdf uploaded. 30 January 2025 18:42 CET Version of Record https://www.mdpi.com/2001-6689/13/1/3/pdf-vor
article html file updated 30 January 2025 18:43 CET Original file -
article xml file uploaded 12 March 2025 14:26 CET Update -
article xml uploaded. 12 March 2025 14:26 CET Update https://www.mdpi.com/2001-6689/13/1/3/xml
article pdf uploaded. 12 March 2025 14:26 CET Updated version of record https://www.mdpi.com/2001-6689/13/1/3/pdf
article html file updated 12 March 2025 14:27 CET Update https://www.mdpi.com/2001-6689/13/1/3/html
Back to TopTop